Philip Astley-sparke

Philip Astley-Sparke is the Chief Executive Officer at Replimune Group Inc in Boston, Massachusetts, with expertise in biotechnology and commercialization. He has a successful track record in leading oncology-focused biopharmaceutical companies and has played a key role in mergers and acquisitions within the pharmaceutical industry. Astley-Sparke's career highlights include his leadership in clinical trials and strategy development in the life sciences sector, particularly in the field of immunology. His current role involves overseeing the growth and development of Replimune Group Inc, a biotech company specializing in oncology treatments.